The two final sets of ASCO-related data (on a polyphenol-rich food supplement and curcuminoids)

Here is the last of our data-based reports from the annual meeting of the American Society for Clinical Oncology (ASCO), which ended last Tuesday. It deals with two presentations that are at least intellectually interesting but do not as yet “translate” into any type of clinical certainty. … READ MORE …